Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Experts recommend two-pronged approach to treating prediabetes Katie Kalvaitis; Stephanie A Portnoy
-
- ALPHA OMEGA: n-3 fatty acids did not reduce major CV events in patients with history of MI
- CV mortality in women linked to levels of dehydroepiandrosterone sulfate
- FDA advisory committee undecided on withdrawal of sibutramine from market
- FDA advisory committee votes against approval for lorcaserin
- FDA restricts rosiglitazone use
- Highlights from the EASD annual meeting
- Highlights from the International Thyroid Congress meeting
- RESPONSE: Nursing intervention led to significant, sustained reductions in CV risk
-
- Peer support a lifeline for many with DSD Anne Tamar-Mattis, JD
- Calcified basal ganglia after thyroidectomy Stephanie L. Lee, MD, PhD, ECNU
- Step up and step out Edward C. Chao, DO
- Male childhood cancer survivors had greater adiposity, CV risk factors
- Should the LDL target be the same for prediabetes as overt diabetes?